The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunity to childhood vaccines following high dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) for germ cell tumors (GCT) with comparison to Hodgkin lymphoma (HL).
 
Darren R. Feldman
Research Funding - Astellas Pharma; Decibel Therapeutics (Inst); Novartis; Seagen
Other Relationship - UpToDate
 
Akeem Ronell Lewis
No Relationships to Disclose
 
Andrea Knezevic
No Relationships to Disclose
 
David Ali
No Relationships to Disclose
 
Maria Bromberg
No Relationships to Disclose
 
Julia Aronson
No Relationships to Disclose
 
Samuel Aaron Funt
Stock and Other Ownership Interests - Allogene Therapeutics; Kite, a Gilead company; Kronos Bio (I); Neogene Therapeutics (I); Urogen pharma (I); Vaxigene Therapeutics; Vaxigene Therapeutics; Vida Ventures (I)
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Immunai; Merck
Research Funding - AstraZeneca (Inst); Decibel Therapeutics (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Deaglan Joseph McHugh
Consulting or Advisory Role - Progenics
 
Robert J. Motzer
Consulting or Advisory Role - AstraZeneca; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Genentech/Roche; Incyte; Lilly; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Dean F. Bajorin
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Dragonfly Therapeutics; Fidia Farmaceutici S. p. A.; Merck
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Seattle Genetics/Astellas (Inst)
Travel, Accommodations, Expenses - Merck
 
Sujata Patil
No Relationships to Disclose
 
Gunjan L. Shah
Research Funding - Amgen; Janssen
 
Monika Shah
No Relationships to Disclose
 
Susan Seo
Research Funding - Merck
 
Mini Kamboj
No Relationships to Disclose
 
Miguel-Angel Perales
Stock and Other Ownership Interests - NexImmune
Honoraria - MorphoSys
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Cidara Therapeutics; Incyte; Kite/Gilead; Medigene; Merck; MolMed; Nektar; NexImmune; Novartis; Omeros; Servier/Pfizer; Takeda; Vor Biopharma
Research Funding - Incyte (Inst); Kite, a Gilead company (Inst); Miltenyi Biotec (Inst); Nektar (Inst); Novartis (Inst)
 
Genofeva Papanicolaou
Consulting or Advisory Role - Adma Pharma; AlloVir; Amplyx Pharmaceuticals; Cidara Therapeutics
Research Funding - Merck; Takeda